The company has also created a diagnostics business unit to put more focus on the emerging opportunity in molecular diagnostics. The diagnostics business unit will develop diagnostic content for the BeadXpress system, and ultimately for Illumina’s Sequencing products.
The company said that the timing of this reorganization was driven by several management changes. John Stuelpnagel, senior vice president, COO and general manager, arrays has decided to move to part-time status as of April 1, 2008. John West, senior vice president and general manager, sequencing has announced his resignation effective February 1, 2008.
Effective immediately, Christian Henry, senior vice president and CFO will take on the role of acting general manager of the sequencing business. In addition to his other duties, Mr Henry’s primary goal will be to effectively manage the integration of the sequencing business into the new combined life sciences business unit.